Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung disease

We present the case of an old woman with ALK-rearranged stage IV lung adenocarcinoma who received crizotinib. She presented with severe dyspnea on the 34th day, and diffuse ground-glass opacifications in her chest. A diagnosis of crizotinib-induced ILD was confirmed. Corticosteroids were administere...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaohong, Guo, Bingpeng, Lin, Xinqing, Qin, Yinyin, Ouyang, Ming, Li, Shiyue, Zhou, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863787/
https://www.ncbi.nlm.nih.gov/pubmed/31250326
http://dx.doi.org/10.1007/s10456-019-09673-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863787/
https://www.ncbi.nlm.nih.gov/pubmed/31250326
http://dx.doi.org/10.1007/s10456-019-09673-1

Ejemplares similares